Let's talk medical research

We caught up with Jack Burks, MD, of the Multiple Sclerosis Association of America (MSAA) to find out his thoughts on what’s new and exciting in Multiple Sclerosis research. Here’s what he had to say:

If you’ve been diagnosed with an illness, you probably know the accompanying feeling of uncertainty all too well. How will this impact your life? What treatment will you select? Will there be side effects? Will it work?

We’ve long followed the Scrip Awards - where the industry’s highest achievers are recognized for outstanding work across the drug development spectrum. And now, we’re thrilled to announce that Antidote has been named a Scrip Awards finalist in two different categories: “Best Technological Development in Clinical Trials,” for our product Antidote Match, and “Community Partnership of the Year” for ...

It’s been an exciting fall here at Antidote. We announced our latest round of funding, grew our partner network to more than 210 partners, and are now finalists for two Scrip Awards. The Scrip Awards provide the industry with the opportunity to recognize its highest achievers across the drug development spectrum— from novel deals, to new drug launches, to technological breakthroughs in clinical ...

November is COPD Awareness Month, a time that COPD patients, caregivers and organizations promote better COPD treatment and the need for research. Nearly 16 million people in the United States have been diagnosed with COPD, and it’s the third leading cause of death in the United States.

Today is the first day of National Diabetes Awareness Month, and to mark the occasion, we had a conversation with three college students, Hannah, Julie, and Natali, who started their own chapter of the College Diabetes Network at the College of New Jersey.

One of the most important results of the work we do at Antidote is directly impacting the lives of patients — and getting to hear their stories is a constant reminder of why we do what we do.

We interviewed Alice Bast, CEO of Beyond Celiac, about her organization and what's next for celiac disease research.

What is Mild Cognitive Impairment? Mild cognitive impairment (MCI) causes slight but noticeable memory changes and thinking problems. These thinking problems are worse than those associated with normal aging, but not as severe as Alzheimer’s disease memory loss symptoms.

Though asthma is a condition that impacts an estimated 27 million Americans, the experience each individual has with it is unique. Depending on the type and severity, managing life with asthma can be a burden — especially if the treatments currently available are not particularly effective.